QUINLAN AMY (Vice President of Finance) reported 3 transactions at VOR BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/4/2024ACC: 0001415889-24-022767
Officer· Vice President of Finance
Since Jun 2024
-4.95K
Net shares
Net seller
$4.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
4.95K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−343.00
Price / share
$0.94
Trade value
$322.42
% of position
0.6%
8/1/2024
55.81K→55.47K
Common Stock
Direct
Shares
−206.00
Price / share
$0.87
Trade value
$179.22
% of position
0.4%
8/6/2024
55.47K→55.26K
Common Stock
Direct
Shares
−4.40K
Price / share
$0.83
Trade value
$3.65K
% of position
8.0%
9/3/2024
55.26K→50.86K
Total
Net shares
−4.95K
Net value
-$4.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2024 | F · Tax Withholding | −343.00 | $0.94 | $322.42 | 0.6% | 55.81K | 55.47K |
| Common Stock Direct | 8/6/2024 | F · Tax Withholding | −206.00 | $0.87 | $179.22 | 0.4% | 55.47K | 55.26K |
| Common Stock Direct | 9/3/2024 | F · Tax Withholding | −4.40K | $0.83 | $3.65K | 8.0% | 55.26K | 50.86K |
| Total | −4.95K | -$4.16K | ||||||
Derivative Transactions0
No derivative transactions reported